J.M.P.G.M. de Vos

Graus, M. U. J. E., van Diepen, A. E., Josemanders, K., Besselink, M. G., Bouwense, S. A. W., Daamen, L. A., de Hingh, I. H. J. T., de Jong, E. J. M., van Laarhoven, H. W. M., de Meijer, V. E., Molenaar, I. Q., Stommel, M. W. J., Iersel, L. B. J. V., Wilmink, J. W., van der Geest, L. G. M., de Vos-Geelen, J., & Dutch Pancreatic Cancer Group (2025). Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic adenocarcinoma: Nationwide population-based study. European Journal of Cancer, 220, Article 115385. https://doi.org/10.1016/j.ejca.2025.115385

Kuijper, S. C., Gehrels, A. M., van Der Geest, L. G., Verhoeven, R. H. A., Koerkamp, B. G., Molenaar, I. Q., Stommel, M. W. J., de Meijer, V. E., de Vos-Geelen, J., Wumkes, M. L., Besselink, M. G., Wilmink, J. W., van Laarhoven, H. W. M., & Dutch Pancreatic Canc Grp (2025). Survival scenarios of patients with localized and metastatic pancreatic adenocarcinoma: A population-based study. International Journal of Cancer, 156(9), 1726-1735. https://doi.org/10.1002/ijc.35267

Hustad, K. S., Koteng, L. H., Urrizola, A., Arends, J., Bye, A., Dajani, O., Deliens, L., Fallon, M., Hjermstad, M. J., Kohlen, M., Kurita, G. P., Lundeby, T., Mitrea, N., Payne, C., Roselló-Keränen, S., Warmbrodt, N., de Wilde, A., Kaasa, S., de Vos-Geelen, J., ... MyPath consortium (2025). Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred care. ESMO Open, 10(4), Article 104529. https://doi.org/10.1016/j.esmoop.2025.104529

Tan, X., Rosin, M., Appinger, S., Deierl, J. C., Reichel, K., Coolsen, M., Valkenburg-van Iersel, L., de Vos-Geelen, J., de Jong, E. J. M., Bednarsch, J., Grootkoerkamp, B., Doukas, M., van Eijck, C., Luedde, T., Dahl, E., Kather, J. N., Sivakumar, S., Knoefel, W. T., Wiltberger, G., ... Heij, L. R. (2025). Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. Scientific Reports, 15(1), Article 9415. https://doi.org/10.1038/s41598-025-94362-x

Willems, R. A. L., Zanetto, A., Campello, E., de Simone, I., Bulato, C., Konings, J., Kramer, M., Tufaha, S., Russo, F. P., Senzolo, M., Burra, P., Ten Cate, H., de Vos-Geelen, J., Roest, M., Simioni, P., de Laat, B., & Huskens, D. (2025). Patients with cirrhosis have a disbalance between coagulation and fibrinolysis resulting in a prothrombotic phenotype. Journal of Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1016/j.jtha.2025.02.034

Hillege, L. E., Barnett, D. J. M., Ziemons, J., Aarnoutse, R., de Vos-Geelen, J., van Geel, R., de Boer, M., van Riet, Y. E. A., Vincent, J., Penders, J., & Smidt, M. L. (2025). The gut microbiota during tamoxifen therapy in patients with breast cancer. Scientific Reports, 15(1), Article 7874. https://doi.org/10.1038/s41598-025-91734-1

Biesma, N. C., Graus, M. U. J. E., Cirkel, G. A., Besselink, M. G., de Groot, J. W. B., Koerkamp, B. G., Herbschleb, K. H., Los, M., Verdonk, R. C., Wilmink, J. W., Cervantes, A., Valle, J. W., Valkenburg-van Iersel, L. B. J., Froeling, F. E. M., Molenaar, I. Q., Daamen, L. A., de Vos-Geelen, J., van Santvoort, H. C., Bockorny, B., ... Dutch Pancreatic Cancer Group (2025). Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study. European Journal of Surgical Oncology, 51(3), Article 109544. https://doi.org/10.1016/j.ejso.2024.109544

Seelen, L. W. F., Augustinus, S., Stoop, T. F., Bouwense, S. A. W., Busch, O. R., Cirkel, G. A., van Eijck, C. H. J., de Vos-Geelen, J., Groot Koerkamp, B., Haj Mohammad, N., de Hingh, I. H. J. T., van Alphen, E., Homs, M. Y. V., Liem, M. S. L., Los, M., de Meijer, V. E., Mekenkamp, L. J. M., Sprangers, M. A. G., Stommel, M. W. J., ... Dutch Pancreatic Cancer Group (2025). Quality of Life Among Patients With Locally Advanced Pancreatic Cancer: A Prospective Nationwide Multicenter Study. Journal of the National Comprehensive Cancer Network, 23(3), 97-104. https://doi.org/10.6004/jnccn.2024.7091

Stoop, T. F., Seelen, L. W. F., van 't Land, F. R., van der Hout, A. C., Scheepens, J. C. M., Ali, M., Stiggelbout, A. M., van der Kolk, B. M., Bonsing, B. A., Lips, D. J., de Groot, D. J. A., van Veldhuisen, E., Kerver, E. D., Manusama, E. R., Daams, F., Kazemier, G., Cirkel, G. A., van Tienhoven, G., Patijn, G. A., ... Et al. (2025). Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. BMC Cancer, 25(1), Article 299. https://doi.org/10.1186/s12885-025-13554-w

Lansbergen, M. F., Dings, M. P. G., Koster, J., Labots, M., Kerver, E. D., Jochems, A., Homs, M. Y. V., de Vos-Geelen, J., Hendriks, M. P., Tanck, M. W. T., Wilmink, J. W., van Laarhoven, H. W. M., & Bijlsma, M. F. (2025). KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer. Med, Article 100601. https://doi.org/10.1016/j.medj.2025.100601